ストックスクリーナーアプリを入手
3.38
4.97%
0.16
アフターアワーズ：
3.39
0.01
+0.30%
Sonnet Biotherapeutics Holdings Inc (SONN) 最新ニュース
Analysts Spot Bullish Divergence in Sonnet BioTherapeutics Holdings Inc.Portfolio Growth Summary & Verified Chart Pattern Signals - newsyoung.net
Why Sonnet BioTherapeutics Holdings Inc. stock attracts strong analyst attentionJuly 2025 Trade Ideas & Daily Stock Momentum Reports - Newser
Can trapped investors hope for a rebound in Sonnet BioTherapeutics Holdings Inc.Portfolio Growth Summary & Low Risk Growth Stock Ideas - Newser
Should you wait for a breakout in Sonnet BioTherapeutics Holdings Inc.Quarterly Portfolio Report & Low Volatility Stock Recommendations - Newser
Using RSI to spot recovery in Sonnet BioTherapeutics Holdings Inc.New Guidance & Safe Entry Point Alerts - Newser
Sonnet BioTherapeutics Holdings Inc. stock prediction for this weekMarket Sentiment Report & Daily Volume Surge Signals - Newser
Smart tools for monitoring Sonnet BioTherapeutics Holdings Inc.’s price actionWeekly Loss Report & AI Driven Price Predictions - Newser
Is Sonnet BioTherapeutics Holdings Inc. building a consolidation baseGDP Growth & Technical Entry and Exit Alerts - Newser
Real time social sentiment graph for Sonnet BioTherapeutics Holdings Inc.Bull Run & Risk Managed Trade Strategies - Newser
Is Sonnet BioTherapeutics Holdings Inc. stock bottoming out2025 Breakouts & Breakdowns & Advanced Technical Signal Analysis - Newser
Sonnet BioTherapeutics Holdings Inc. Stock Performance After Earnings: Historical Insights2025 Market Overview & Fast Moving Trade Plans - Newser
Real time alert setup for Sonnet BioTherapeutics Holdings Inc. performance2025 Volume Leaders & Daily Price Action Insights - Newser
Is this a good reentry point in Sonnet BioTherapeutics Holdings Inc.2025 Historical Comparison & Weekly Top Gainers Trade List - Newser
Sonnet BioTherapeutics Holdings Inc. stock daily chart insights2025 Major Catalysts & AI Powered Buy/Sell Recommendations - Newser
Analyzing net buyer seller activity in Sonnet BioTherapeutics Holdings Inc.Options Play & Daily Profit Focused Stock Screening - Newser
Published on: 2025-08-16 23:11:22 - Newser
How to monitor Sonnet BioTherapeutics Holdings Inc. with trend dashboardsForecast Cut & Free Technical Pattern Based Buy Signals - Newser
What is the PEG ratio of Sonnet BioTherapeutics Holdings Inc.2025 Key Lessons & Reliable Trade Execution Plans - 선데이타임즈
Sonnet Biotherapeutics Faces Earnings Volatility with New HYPE Treasury Strategy and Accounting Standards - MSN
Sonnet Biotherapeutics Holdings Faces Earnings Volatility with New HYPE Treasury Strategy and Accounting Standards - AInvest
Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Sonnet Releases Virtual Investor What This Means Segment - MarketScreener
Pilot Killed In NJ Crash Was CEO Of Cancer-Focused Biotech Company - MSN
Sonnet Releases Virtual Investor 'What This Means' Segment - The Manila Times
Sonnet Releases Virtual Investor "What This Means" Segment - GlobeNewswire
Breakthrough: Sonnet's Ovarian Cancer Drug Achieves 67% Response Rate, Trial Expands with Higher Dose - Stock Titan
Why Did Sonnet BioTherapeutics Holdings Soar 11.49%? - AInvest
Sonnet BioTherapeutics Holdings Inc. Added to High Probability Setup ListStock Portfolio Allocation Guidance for Volatile Markets - beatles.ru
Short Interest Drops in Sonnet BioTherapeutics Holdings Inc. After RallyOptimized Watchlist With Daily Adjustments Launched - beatles.ru
Sonnet Biotherapeutics Holdings Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
This Cancer Biotech Company Is Making a Big Bet on the HYPE Crypto. Should You Buy Its Stock Here? - Yahoo Finance
Sonnet BioTherapeutics Expands Clinical Study of SON-1010 in Combination with Atezolizumab for Advanced Platinum-Resistant Ovarian Cancer - Quiver Quantitative
Sonnet BioTherapeutics Expands Clinical Evaluation of - GlobeNewswire
Cancer Drug Shows 66% Response Rate in Ovarian Cancer Trial: Sonnet BioTherapeutics Advances to Higher Dose - Stock Titan
Live Chart Scan Detects Wedge Pattern in Sonnet BioTherapeutics Holdings Inc.Swing Trade Entry With Volume Triggers Released - beatles.ru
Is Sonnet BioTherapeutics Holdings Inc. stock overvalued or undervaluedRecord-breaking capital gains - Jammu Links News
What is the dividend policy of Sonnet BioTherapeutics Holdings Inc. stockBuild wealth faster with disciplined trading - Jammu Links News
Why is Sonnet BioTherapeutics Holdings Inc. stock attracting strong analyst attentionCapitalize on proven investment strategies - Jammu Links News
How strong is Sonnet BioTherapeutics Holdings Inc. company’s balance sheetFree Daily Trading Room Entry - Jammu Links News
What analysts say about Sonnet BioTherapeutics Holdings Inc. stockIdentify undervalued stocks poised to rally - Jammu Links News
What are the latest earnings results for Sonnet BioTherapeutics Holdings Inc.Fastest return on investment - Jammu Links News
What institutional investors are buying Sonnet BioTherapeutics Holdings Inc. stockExpert guidance for superior capital growth - Jammu Links News
What is the risk reward ratio of investing in Sonnet BioTherapeutics Holdings Inc. stockTransform your portfolio with high-yield stocks - Jammu Links News
What drives Sonnet BioTherapeutics Holdings Inc. stock priceStay ahead with daily market updates - Jammu Links News
What catalysts could drive Sonnet BioTherapeutics Holdings Inc. stock higher in 2025Dynamic profit expansion - Jammu Links News
Is it the right time to buy Sonnet BioTherapeutics Holdings Inc. stockHigh-velocity gains - Jammu Links News
Sonnet BioTherapeutics Appoints Interim CEO Raghu Rao - The Globe and Mail
Sonnet BioTherapeutics enters employment agreement with interim CEO Raghu Rao - Investing.com Australia
Is Sonnet BioTherapeutics Holdings Inc. a growth stock or a value stockBest Dividend Insights For Fast Growth - Jammu Links News
1.55%
0.38%
大文字化:
|
ボリューム (24 時間):